SDC1 and synovial sarcoma: Further, the study found significantly higher salivary CD138 levels in SS patients compared to healthy patients and a positive correlation between plasma CD138 levels and SS disease activity, suggesting CD138 as a potential biomarker for disease activity in SS [22].